These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 10652649)

  • 21. [Double-blind trial of the effectiveness of antibodies to interferon-gamma and tumor necrosis factor-alpha in rheumatoid arthritis (preliminary results)].
    Lukina GV; Sigidin IaA; Skurkovich SV; Skurkovich BS
    Ter Arkh; 2001; 73(5):12-5. PubMed ID: 11517739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of rheumatoid arthritis with anti-TNF-alpha agents: a reappraisal.
    Caporali R; Pallavicini FB; Filippini M; Gorla R; Marchesoni A; Favalli EG; Sarzi-Puttini P; Atzeni F; Montecucco C
    Autoimmun Rev; 2009 Jan; 8(3):274-80. PubMed ID: 19017546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Gene transfer immunotherapy in rheumatoid arthritis: perspectives].
    Jorgensen C
    Rev Med Interne; 2001 Feb; 22(2):163-71. PubMed ID: 11234674
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modeling the 5-year cost effectiveness of treatment strategies including tumor necrosis factor-blocking agents and leflunomide for treating rheumatoid arthritis in the Netherlands.
    Welsing PM; Severens JL; Hartman M; van Riel PL; Laan RF
    Arthritis Rheum; 2004 Dec; 51(6):964-73. PubMed ID: 15593319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The anti-tumor necrosis factor agents are a major advance in the treatment of rheumatoid arthritis.
    Haraoui B
    J Rheumatol Suppl; 2005 Jan; 72():46-7. PubMed ID: 15660467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New therapeutic approaches for rheumatoid arthritis.
    Abdelaty EM; Schumacher HR
    Int J Clin Pract; 1999; 53(7):535-9. PubMed ID: 10692740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. I have rheumatoid arthritis and have been taking methotrexate. I'm interested in the new drugs that have been in the news lately. Just how effective are they?
    Robb-Nicholson C
    Harv Womens Health Watch; 1999 Feb; 6(6):8. PubMed ID: 9973895
    [No Abstract]   [Full Text] [Related]  

  • 28. [Leflunomide: a new treatment for an old disease].
    Monteagudo Sáez I; López Longo FJ; González Fernández CM; Carreño Pérez L
    Rev Clin Esp; 2000 May; 200 Monog 1():114-8. PubMed ID: 10901036
    [No Abstract]   [Full Text] [Related]  

  • 29. Strategies for active TNF-α vaccination in rheumatoid arthritis treatment.
    Jia T; Pan Y; Li J; Wang L
    Vaccine; 2013 Aug; 31(38):4063-8. PubMed ID: 23845805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor necrosis factor inhibitors for rheumatoid arthritis.
    Jones RE; Moreland LW
    Bull Rheum Dis; 1999; 48(3):1-4. PubMed ID: 10408141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leflunomide and rheumatoid arthritis: new preparation. Neither the safest nor the most effective slow-acting antirheumatic drug.
    Prescrire Int; 2001 Apr; 10(52):36-9. PubMed ID: 11718154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rheumatoid arthritis drugs show promise.
    Mayo Clin Health Lett; 1999 Jan; 17(1):4. PubMed ID: 9919935
    [No Abstract]   [Full Text] [Related]  

  • 33. [New immunologic treatment of rheumatoid arthritis].
    Sany J
    Rev Rhum Ed Fr; 1993 Mar; 60(3):229-39. PubMed ID: 8293009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Switching TNF-alpha antagonists in rheumatoid arthritis: the experience of the LORHEN registry.
    Caporali R; Sarzi-Puttini P; Atzeni F; Gorla R; Filippini M; Marchesoni A; Favalli EG; Bobbio-Pallavicini F; Montecucco C
    Autoimmun Rev; 2010 Apr; 9(6):465-9. PubMed ID: 20044040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical improvement as reflected in measures of function and health-related quality of life following treatment with leflunomide compared with methotrexate in patients with rheumatoid arthritis: sensitivity and relative efficiency to detect a treatment effect in a twelve-month, placebo-controlled trial. Leflunomide Rheumatoid Arthritis Investigators Group.
    Tugwell P; Wells G; Strand V; Maetzel A; Bombardier C; Crawford B; Dorrier C; Thompson A
    Arthritis Rheum; 2000 Mar; 43(3):506-14. PubMed ID: 10728742
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of leflunomide versus biologic agents on the costs of care for rheumatoid arthritis in a managed care population.
    Ollendorf DA; Peterson AN; Doyle J; Huse DM
    Am J Manag Care; 2002 May; 8(7 Suppl):S203-13. PubMed ID: 12022236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leflunomide in active rheumatoid arthritis: a prospective study in daily practice.
    Van Roon EN; Jansen TL; Mourad L; Houtman PM; Bruyn GA; Griep EN; Wilffert B; Tobi H; Brouwers JR
    Br J Clin Pharmacol; 2004 Jun; 57(6):790-7. PubMed ID: 15151525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost effectiveness of adding leflunomide to a 5-year strategy of conventional disease-modifying antirheumatic drugs in patients with rheumatoid arthritis.
    Maetzel A; Strand V; Tugwell P; Wells G; Bombardier C
    Arthritis Rheum; 2002 Dec; 47(6):655-61. PubMed ID: 12522841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T cells: pathogenic cells and therapeutic targets in rheumatoid arthritis.
    Yocum DE
    Semin Arthritis Rheum; 1999 Aug; 29(1):27-35. PubMed ID: 10468412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cartilage destruction and bone erosion in arthritis: the role of tumour necrosis factor alpha.
    Williams RO; Feldmann M; Maini RN
    Ann Rheum Dis; 2000 Nov; 59 Suppl 1(Suppl 1):i75-80. PubMed ID: 11053094
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.